aTyr Pharma

MONTREAL, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cerro de Pasco Resources Inc. (CSE: CDPR) (OTCQB: GPPRF) (FRA: N8HP) (“CDPR” or the “Corporation”) announces that is has filed an amended and restated offering document dated November 19, 2024 (the “A&R Offering Document”) in connection with its previously announced brokered “best-efforts” private placement led by SCP Resource Finance LP, on behalf of itself and a syndicate of agents (hereinafter referred to collectively as the “Agents”). Pursuant to the A&R Offering Document, the Corporation offers, in each provinces of Canada, 33,333,333 units of the Corporation (each, a “Unit”) at a price of $0.30 per Unit (the “Offering Price”) for gross proceeds of $10,000,000 pursuant to the listed issuer financing exemption (the “Listed Issuer Financing Exemption”) under Part 5A of National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”) (the “LIFE Offering”) and a minimum of 16,666,667 Units at the Offering Price by way of a concurrent brokered private placement to certain purchasers (i) pursuant to applicable exemptions under NI 45-106, (ii) purchasers resident in the United States pursuant to one or more available exemptions from the registration requirements of the U.S. Securities Act, and (iii) purchasers outside of Canada and the United States on a basis which does not require the qualification or registration of any of the Corporation's securities and the Corporation to be subject to any ongoing disclosure requirements, under domestic or foreign securities laws, for additional gross proceeds to the Corporation of $5,000,000 (the “Concurrent Private Placement”, and collectively with the LIFE Offering, the “Minimum Offering”).» Mehr auf globenewswire.com

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”) is pleased to announce that it closed the second tranche of its previously announced non-brokered private placement (the "LIFE Offering") of units of the Company (the "LIFE Units") for aggregate gross proceeds in this second tranche of $512,800. The first tranche of the LIFE Offering closed on November 8, 2024 for aggregate gross proceeds of $2,903,850.» Mehr auf globenewswire.com

MCKINNEY, Texas , Nov. 15, 2024 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has declared a quarterly dividend of $.2400 per share on all of the outstanding common stock of the Company held of record as of close of business of the Company's transfer agent on January 6, 2025. The dividend will be paid on January 31, 2025.» Mehr auf prnewswire.com